Pacific Biosciences Of California | PACB - Operating Profit

Stock Price
1.71
Daily Change
-0.13 -7.07%
Monthly
-27.54%
Yearly
-7.57%
Q1 Forecast
3.50

Pacific Biosciences Of California reported $-64.08M in Operating Profit for its fiscal quarter ending in September of 2024.





Operating Profit Change Date
Agilent USD 443M 66M Sep/2025
Bruker USD 76.3M 7.6M Dec/2025
Danaher USD 1.5B 348M Dec/2025
General Electric Aerospace USD 1.77B 536M Dec/2025
Illumina USD 256M 6M Dec/2025
Myriad Genetics USD -23.3M 10.8M Sep/2025
Pacific Biosciences Of California USD -64.08M 111.77M Sep/2024
Quidel USD -37.3M 667.5M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Standard Biotools USD -23.47M 230K Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Waters USD 270.52M 78.4M Dec/2025